Open AccessMolnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs
Author(s) -
Louis D. Saravolatz,
Shawn Depcinski,
Mamta Sharma
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac180
Subject(s) - ritonavir , medicine , lopinavir , adverse effect , drug , protease inhibitor (pharmacology) , pharmacology , coronavirus , antiviral drug , pharmacokinetics , virology , viral load , disease , covid-19 , virus , infectious disease (medical specialty) , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom